FI20075251A0 - Immunomääritys epästabiilien antigeenien määrittämiseksi - Google Patents

Immunomääritys epästabiilien antigeenien määrittämiseksi

Info

Publication number
FI20075251A0
FI20075251A0 FI20075251A FI20075251A FI20075251A0 FI 20075251 A0 FI20075251 A0 FI 20075251A0 FI 20075251 A FI20075251 A FI 20075251A FI 20075251 A FI20075251 A FI 20075251A FI 20075251 A0 FI20075251 A0 FI 20075251A0
Authority
FI
Finland
Prior art keywords
immunoassay
detection
unstable antigens
antigens
unstable
Prior art date
Application number
FI20075251A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Inventor
Natalya Tamm
Alexey Katrukha
Vladimir Filatov
Olga Kolosova
Original Assignee
Hytest Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hytest Oy filed Critical Hytest Oy
Priority to FI20075251A priority Critical patent/FI20075251A0/fi
Publication of FI20075251A0 publication Critical patent/FI20075251A0/fi
Priority to US12/595,463 priority patent/US9034591B2/en
Priority to CA2683911A priority patent/CA2683911C/fr
Priority to ES08736833.8T priority patent/ES2599635T3/es
Priority to EP08736833.8A priority patent/EP2135087B1/fr
Priority to CN200880011741.2A priority patent/CN101842707B/zh
Priority to JP2010502538A priority patent/JP5686593B2/ja
Priority to PCT/FI2008/050184 priority patent/WO2008125733A1/fr
Priority to DK08736833.8T priority patent/DK2135087T3/en
Priority to US13/600,873 priority patent/US9034592B2/en
Priority to US14/689,486 priority patent/US9145459B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2470/00—Immunochemical assays or immunoassays characterised by the reaction format or reaction type
    • G01N2470/04—Sandwich assay format
    • G01N2470/06—Second binding partner specifically binding complex of analyte with first binding partner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI20075251A 2007-04-13 2007-04-13 Immunomääritys epästabiilien antigeenien määrittämiseksi FI20075251A0 (fi)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FI20075251A FI20075251A0 (fi) 2007-04-13 2007-04-13 Immunomääritys epästabiilien antigeenien määrittämiseksi
DK08736833.8T DK2135087T3 (en) 2007-04-13 2008-04-14 IMMUNOASSAY TO QUANTIFY A USTABLE ANTIGEN SELECTED FROM GDP AND PROBNP
EP08736833.8A EP2135087B1 (fr) 2007-04-13 2008-04-14 Immuno-dosage pour la quantification d'un antigène instable sélectionné à partir de bnp et probnp
CA2683911A CA2683911C (fr) 2007-04-13 2008-04-14 Immuno-dosage pour la quantification d' un antigene instable selectionne a partir de bnp et probnp
ES08736833.8T ES2599635T3 (es) 2007-04-13 2008-04-14 Inmunoanálisis para la cuantificación de un antígeno inestable seleccionado de BNP y proBNP
US12/595,463 US9034591B2 (en) 2007-04-13 2008-04-14 Immunoassay for quantification of an unstable antigen selected from BNP and proBNP
CN200880011741.2A CN101842707B (zh) 2007-04-13 2008-04-14 用于对选自bnp和bnp原的不稳定抗原定量的免疫测定法
JP2010502538A JP5686593B2 (ja) 2007-04-13 2008-04-14 ＢＮＰおよびｐｒｏＢＮＰからなる群より選ばれる不安定な抗原を定量するための免疫アッセイ
PCT/FI2008/050184 WO2008125733A1 (fr) 2007-04-13 2008-04-14 Immuno-dosage pour la quantification d' un antigène instable sélectionné à partir de bnp et probnp
US13/600,873 US9034592B2 (en) 2007-04-13 2012-08-31 Immunoassay for quantification of an unstable antigen selected from BNP and proBNP
US14/689,486 US9145459B2 (en) 2007-04-13 2015-04-17 Immunoassay kit for quantification of BNP and proBNP

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20075251A FI20075251A0 (fi) 2007-04-13 2007-04-13 Immunomääritys epästabiilien antigeenien määrittämiseksi

Publications (1)

Publication Number Publication Date
FI20075251A0 true FI20075251A0 (fi) 2007-04-13

Family

ID=38009904

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20075251A FI20075251A0 (fi) 2007-04-13 2007-04-13 Immunomääritys epästabiilien antigeenien määrittämiseksi

Country Status (9)

Country Link
US (3) US9034591B2 (fr)
EP (1) EP2135087B1 (fr)
JP (1) JP5686593B2 (fr)
CN (1) CN101842707B (fr)
CA (1) CA2683911C (fr)
DK (1) DK2135087T3 (fr)
ES (1) ES2599635T3 (fr)
FI (1) FI20075251A0 (fr)
WO (1) WO2008125733A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2919611B1 (fr) 2007-08-03 2009-10-23 Bio Rad Pasteur Sa Nouvel epitope du bnp (1-32) et anticorps diriges contre cet epitope
CA2807240A1 (fr) 2010-08-04 2012-02-09 Idexx Laboratories, Inc. Detection des produits de degradation du nt-probnp canin
JP2012140331A (ja) * 2010-12-28 2012-07-26 Tosoh Corp タグペプチド
US9244073B2 (en) 2011-02-25 2016-01-26 Wellstat Diagnostics, Llc Assays for detecting enzymatic activity
AU2012262154B2 (en) 2011-05-31 2016-08-04 Idexx Laboratories, Inc. Detection of degradation products of feline NT-proBNP
IN2014CN02113A (fr) 2011-09-21 2015-05-29 Fujirebio Kk
CN102608335A (zh) * 2012-04-19 2012-07-25 协和生物制药（天津）有限公司 NT-proBNP时间分辨荧光免疫分析试剂盒的制备方法
EP4014041A1 (fr) 2019-08-13 2022-06-22 Gentian AS Dosage amélioré en particules hautement sensibles destiné à la quantification de nt-probnp
CN113956355B (zh) * 2021-07-26 2023-06-23 无锡傲锐东源生物科技有限公司 抗人脑利钠肽(bnp)兔单克隆抗体及其应用
WO2023052642A1 (fr) 2021-10-01 2023-04-06 Gentian As Nouveau procédé de détermination d'une concentration de pro-hormone bnp n-terminale (nt-probnp) dans un échantillon

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583003A (en) * 1989-09-25 1996-12-10 Agen Limited Agglutination assay
CA2072758A1 (fr) 1990-09-14 1992-03-15 Kenneth Francis Buechler Anticorps liant aux complexes de recepteurs de ligands et de ligands et leur utilite dans les tests ligand-recepteur
US6828107B2 (en) * 1997-09-11 2004-12-07 Shionogi & Co., Ltd. Immunoassay method for BNP
US20030219734A1 (en) 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
CA2430889A1 (fr) 2002-06-19 2003-12-19 Bayer Corporation Stabilisation du peptide natriuretique cerebral (bnp) dans des echantillons de sang, et methodes et composes connexes
FI20022048A0 (fi) * 2002-11-18 2002-11-18 Valtion Teknillinen Ei-kompetetiivinen immunomääritys pienille analyyteille
KR100771999B1 (ko) * 2004-05-20 2007-10-31 김상돈 그레이팅
US7731965B2 (en) * 2005-02-17 2010-06-08 Abbott Lab Human ring specific BNP antibodies
CA2629438C (fr) * 2005-11-09 2014-02-25 Abbott Laboratories Anticorps immunospecifiques du bnp humain
EP2021369A2 (fr) 2006-05-26 2009-02-11 Hytest Ltd. ANTICORPS ET NORME POUR IMMUNOESSAIS DESTINÉS À LA DÉTECTION DES MARQUEURS NT-proBNP ET proBNP
US20080064045A1 (en) 2006-09-07 2008-03-13 Huaiqin Wu Biomarker fragments for the detection of human BNP

Also Published As

Publication number Publication date
CN101842707B (zh) 2016-11-09
EP2135087B1 (fr) 2016-09-14
WO2008125733A8 (fr) 2009-07-30
WO2008125733A1 (fr) 2008-10-23
EP2135087A1 (fr) 2009-12-23
US9034591B2 (en) 2015-05-19
EP2135087A4 (fr) 2011-06-22
DK2135087T3 (en) 2016-11-14
JP5686593B2 (ja) 2015-03-18
US20130071949A1 (en) 2013-03-21
US9034592B2 (en) 2015-05-19
JP2010523994A (ja) 2010-07-15
CN101842707A (zh) 2010-09-22
US20100203560A1 (en) 2010-08-12
US20150219675A1 (en) 2015-08-06
ES2599635T3 (es) 2017-02-02
CA2683911A1 (fr) 2008-10-23
CA2683911C (fr) 2017-01-10
US9145459B2 (en) 2015-09-29

Similar Documents

Publication Publication Date Title
CY2019004I1 (el) Τροποποιημενα αντισωματα αντι-ιl-23ρ19
CY2019041I1 (el) Τροποποιημενα αντισωματα εναντι il-23
CY2016030I1 (el) Αντισωματα εναντι της il-17
FI20075251A0 (fi) Immunomääritys epästabiilien antigeenien määrittämiseksi
BRPI0817637A2 (pt) anticorpo anti-glipican-3 tendo cinéticas aperfeiçoadas no plasma
BRPI0809677A2 (pt) Anticorpos anti-ige
BRPI0817273A2 (pt) Região constante de anticorpo modificada
BRPI0907237A2 (pt) Anticorpo anti-cldn6
BRPI0819165A2 (pt) Anticorpos anti-vegf
DK2059533T3 (da) Multispecifikke antistoffer
NO20076607L (no) TWEAK - bindende antistoff
DK1964852T3 (da) Anti-ilt7-antistof
DK2234600T3 (da) Antistofformulering
BRPI0906877A2 (pt) Anticorpos anti-trkb aperfeiçoados
DK2131860T3 (da) Anti-sclerostin-antistoffer
DK2066695T3 (da) Anti-myostatin-antistoffer
NO344963B1 (no) Humanisert antistoff
BRPI0815567A2 (pt) Anticorpos híbridos antialfa v-integrina projetados
BRPI0923359A2 (pt) Anticorpos anti-igf
DE602006013591D1 (de) Such-/Detektionsgerät
BRPI0819210A2 (pt) Anticorpos de proteína g anti-rsv
BRPI0817427A2 (pt) Anticorpo anti-bst2
BRPI0807991A2 (pt) Anticorpos anti-il-23r elaborados.
BRPI0915491A2 (pt) sensor de imunoensaio
CR10705A (es) Anticuerpos para linfotoxina-alfa